Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+27.81%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$40.3B
AUM Growth
+$6.52B
(+19%)
Cap. Flow
-$944M
Cap. Flow
% of AUM
-2.34%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
2,488
New
258
Increased
811
Reduced
1,082
Closed
259
Top Buys
| 1 |
IBM
IBM
|
$243M |
| 2 |
3M
MMM
|
$147M |
| 3 |
Bristol-Myers Squibb
BMY
|
$141M |
| 4 |
Public Service Enterprise Group
PEG
|
$107M |
| 5 |
KeyCorp
KEY
|
$84.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$379M |
| 2 |
Kimberly-Clark
KMB
|
$190M |
| 3 |
AbbVie
ABBV
|
$157M |
| 4 |
Altria Group
MO
|
$142M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$119M |
Sector Composition
| 1 | Healthcare | 22.22% |
| 2 | Technology | 18.82% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Financials | 9.92% |
| 5 | Industrials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Bio-Rad Laboratories Class A
BIO
$8B
| $38.3M | 0.09% |
84,777
-47,755
| -36% | -$21.6M |
|
|
EGIO
252
DELISTED
Edgio, Inc. Common Stock
EGIO
| $38.1M | 0.09% |
129,375
+12,309
| +11% | +$3.62M |
|
253
Openlane
KAR
$3.09B
| $37.5M | 0.09% |
2,725,840
+821,393
| +43% | +$11.3M |
|
254
Charles River Laboratories
CRL
$8.07B
| $37.1M | 0.09% |
212,773
-9,295
| -4% | -$1.62M |
|
255
Penumbra
PEN
$11B
| $37M | 0.09% |
206,981
-31,205
| -13% | -$5.58M |
|
256
Alphabet (Google) Class C
GOOG
$2.84T
| $37M | 0.09% |
522,860
+42,500
| +9% | +$3M |
|
|
AMRN
257
Amarin Corp
AMRN
$311M
| $36.7M | 0.09% |
265,015
+93,000
| +54% | +$12.9M |
|
258
Keysight
KEYS
$28.9B
| $36.5M | 0.09% |
361,888
-190,661
| -35% | -$19.2M |
|
259
Applied Materials
AMAT
$130B
| $36.2M | 0.09% |
598,324
+166,912
| +39% | +$10.1M |
|
|
NATI
260
DELISTED
National Instruments Corp
NATI
| $36.2M | 0.09% |
934,213
-191,501
| -17% | -$7.41M |
|
261
Advanced Drainage Systems
WMS
$11.5B
| $36.1M | 0.09% |
730,499
+466,182
| +176% | +$23M |
|
|
DISCA
262
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $36M | 0.09% |
1,703,985
+278,393
| +20% | +$5.87M |
|
|
SMAR
263
DELISTED
Smartsheet Inc.
SMAR
| $35.9M | 0.09% |
704,766
+4,766
| +0.7% | +$243K |
|
264
Sarepta Therapeutics
SRPT
$1.96B
| $35.9M | 0.09% |
223,790
+25,086
| +13% | +$4.02M |
|
265
Domo
DOMO
$603M
| $35.5M | 0.09% |
1,102,454
+102,345
| +10% | +$3.29M |
|
266
Eli Lilly
LLY
$652B
| $35.4M | 0.09% |
215,427
-223,415
| -51% | -$36.7M |
|
267
Zscaler
ZS
$42.7B
| $35.3M | 0.09% |
322,596
+83,796
| +35% | +$9.18M |
|
268
Booz Allen Hamilton
BAH
$12.6B
| $35M | 0.09% |
450,293
+79,818
| +22% | +$6.21M |
|
|
AZUL
269
DELISTED
Azul
AZUL
| $34.9M | 0.09% |
3,120,400
-219,900
| -7% | -$2.46M |
|
270
Genmab
GMAB
$16.9B
| $34.8M | 0.09% |
1,025,462
-38,285
| -4% | -$1.3M |
|
271
Minerva Neurosciences
NERV
$16.4M
| $34.7M | 0.09% |
1,201,275
| – | – |
|
272
Hologic
HOLX
$14.8B
| $34.7M | 0.09% |
608,058
-56,214
| -8% | -$3.2M |
|
273
Parker-Hannifin
PH
$96.1B
| $34.5M | 0.09% |
188,375
+55,578
| +42% | +$10.2M |
|
|
TMX
274
DELISTED
Terminix Global Holdings, Inc.
TMX
| $34.2M | 0.08% |
959,008
-240,455
| -20% | -$8.58M |
|
275
Markel Group
MKL
$24.2B
| $34.1M | 0.08% |
36,944
+18
| +0% | +$16.6K |
|